Skip to main content
logo
Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
1.670
-0.040 (-2.34%)
At close: Aug 1, 2025, 4:00 PM
1.730
+0.060 (3.59%)
After-hours: Aug 1, 2025, 7:59 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Exemplar
6.15M
Log In
Log In
Log In
Log In
Upgrade
Exemplar Growth
-48.81%
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceuticals
75.00K
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceuticals Growth
-99.50%
Log In
Log In
Log In
Log In
Upgrade
Trans Ova
-
Log In
Log In
Log In
Log In
Upgrade
Trans Ova Growth
-
Log In
Log In
Log In
Log In
Upgrade
Human Biotherapeutics
-
Log In
Log In
Log In
Log In
Upgrade
All Other
-
Log In
Log In
Log In
Log In
Upgrade
All Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
ActoBio
-
Log In
Log In
Log In
Log In
Upgrade
ActoBio Growth
-
Log In
Log In
Log In
Log In
Upgrade
PGEN Therapeutics, Inc.
-
Log In
Log In
Log In
Log In
Upgrade
PGEN Therapeutics, Inc. Growth
-
Log In
Log In
Log In
Log In
Upgrade
MBP Titan
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
6.23M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-76.66%
Log In
Log In
Log In
Log In
Upgrade
Foreign
-
Log In
Log In
Log In
Log In
Upgrade
Foreign Growth
-
Log In
Log In
Log In
Log In
Upgrade